HOME >> BIOLOGY >> NEWS
Scientists discover key step in the development of nerve cells controlling autonomic functions

Montreal, July 13, 2004. Scientists at the Montreal Neurological Institute at McGill University have discovered a gene that is necessary for the correct development of the part of the brain that controls autonomic functions such as heart rate, bronchial dilation and gut peristalsis. In a study published in the Proceedings of the National Academy of Sciences of the USA, Dr. Stefano Stifani and colleagues have demonstrated for the first time that disruption of this gene causes a dramatic loss of these particular nerve cells.

During the development of the nervous system, there are a number of critical events that generate different types of nerve cells in particular locations of the brain and at particular times. "We found that specific types of hindbrain visceral motor nerve cells do not develop when the function of a gene called Runx1 is disrupted in mice, while other types of nerve cells develop normally", explained Dr. Stefano Stifani, Associate Professor of Neurology and Neurosurgery and Anatomy and Cell Biology. "This has never been shown before and it is an important step in understanding how these nerve cells form during normal development."

The hindbrain visceral motor nerve cells normally control the ability to maintain a stable internal environment in response to internal or external influences. Problems associated with their development or function could have important implications for the control of vital body functions such as blood pressure, heart rate, and electrolyte balance.

These results describe a new function for Runx1, which has a well documented role in the development of blood cells. In humans, Runx1 is called AML1. AML1 is the most frequent target of chromosomal translocations that cause acute myeloid leukemia. "This is a significant finding as it suggests for the first time that similar mechanisms involving Runx1 play roles in motor nerve cell and blood cell development and importantly it provides a new avenue
'"/>

Contact: Sandra McPherson
sandra.mcpherson@mcgill.ca
514-398-1902
McGill University
13-Jul-2004


Page: 1 2 3

Related biology news :

1. Scientists to prototype cyberinfrastructure for research and education access to ocean observatories
2. Scientists sequence genome of kind of organism central to biospheres carbon cycle
3. Scientists find nanowires capable of detecting individual viruses
4. Scientists discover potential new way to control drug-resistant bacteria
5. Scientists explore genome of methane-breathing microbe
6. Scientists decipher genetic code of biothreat pathogen
7. Stuck on you: Scientists lay bare secrets of bacterial attachment proteins
8. Scientists discover proteins involved in spread of HIV-1 infection
9. Scientists fear new Ebola outbreak may explain sudden gorilla disappearance
10. Scientists reinvent DNA as template to produce organic molecules
11. Scientists visualise cellular handmaiden that restores shape to proteins

Post Your Comments:
(Date:6/18/2013)... has awarded $12.7 million to match nine academic ... compounds to explore new treatments for patients in ... dystrophy and schizophrenia. The collaborative pilot initiative, called ... led by the National Center for Advancing Translational ... Fund. , The process of developing a new ...
(Date:6/18/2013)... of breast and ovarian cancers are familial in origin, ... to inherited mutations from the parents in genes such ... PARP inhibitors, which are currently in clinical trials, have ... for personalised cancer treatment, an alternative to standard chemotherapy. ... these patients generate resistance to the drug and, therefore, ...
(Date:6/17/2013)... in the U.S. exposed to high levels of air pollution ... a child with autism as women who lived in areas ... School of Public Health (HSPH). It is the first large ... across the U.S. , "Our findings raise concerns since, depending ... our study lived in areas where risk of autism was ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
(Date:6/18/2013)... -- RegeneCure announced today the start ... Bone Regeneration (GBR) Dental Membrane as a bone stimulating aid ... encountered when patients have a tooth replaced with a dental ... the implant. Consequently there is often a need to support ... regenerates. The bone substitute material, in turn, needs to be ...
(Date:6/18/2013)... , June 18, 2013 ... investment research firm, announces the initiation of ... French biopharmaceutical company developing and marketing products ... indications.      (Logo: http://photos.prnewswire.com/prnh/20130417/608168) ... report examining the investment merits of BioAlliance ...
(Date:6/18/2013)... June 18, 2013 Mapi Pharma Ltd. ... and innovative intermediates, and finished dosage forms based on selected ... granted a United States patent for ... Europe for the oral treatment of moderate-to-severe acute ... Intermediate Compounds and Processes for the Preparation of Tapentadol ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/5g3rx5/dna_sequencing ) has announced the addition of ... Markets and Companies " to their offering. ... This report briefly reviews basics of human ... their applications. Current large and small sequencers ...
Breaking Biology Technology:RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 2Edison Expands French Healthcare Sector Coverage With Initiation of Coverage on BioAlliance Pharma 3Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2DNA Sequencing: Technologies, Markets and Companies - 2013 Report 2
Cached News: